Brain protein was lower in mouse models of memory problems
Compared with controls, mouse models of Alzheimer’s disease, diabetes-related brain impairment and brain aging had less of a protein that helps organize nerve-cell connections.

Our read
Mechanisms- Studied:
- Preprint: experiments in mice modeling cognitive impairment, against control mice
- What changed:
- Hippocampal BAIAP2 protein levels were lower in mice modeling memory problems than in control mice
- The catch:
- Memory effects of directly changing BAIAP2 levels were not measured
- In the record:
- One of 17 papers on amyloid-beta on record: 3 with results in people, 6 in animals.
- Why it’s aging research:
- Biological age, frailty, function, multimorbidity or death.
Editor of record: Boris Djordjevic · AgingResearch.News
Mice modeling Alzheimer’s disease, diabetes-related brain impairment and brain aging showed problems remembering locations in animal experiments. Compared with controls, all three model groups had lower levels of BAIAP2, a protein that helps organize nerve-cell connections, in the hippocampus, a brain region involved in memory. Activity of the gene encoding this protein was also lower.
The researchers first analyzed gene activity in individual cells from three existing datasets. BAIAP2 was the only shared central gene in networks of nerve-cell gene activity associated with the three conditions. In separate experiments, nerve-like cells grown in the lab also had lower BAIAP2 gene activity and protein levels after exposure to stimuli used to mimic Alzheimer’s disease, metabolic stress or aging-related damage.
Why it matters
Brain aging and these disorders share damage to nerve-cell connections. The authors propose BAIAP2 as a potential common target for strategies against cognitive decline.
Caveats
The experiments did not test whether changing BAIAP2 caused or corrected memory problems; lower levels could accompany rather than cause the impairment. The work is a preprint and has not yet been peer-reviewed.
Where the evidence stands
Cellular senescence
- 854 independent labs in 75 countries
- 515 findings against
- 51 trials, 15 with no results posted
- Funders: National Natural Science Foundation of China and others
- 663 of 9,839 findings with company ties
- 49 of 51 trials sponsored by developers of drugs aimed at it
The paper
Tianjin University of Traditional Chinese Medicine
Research Square, Nov 3, 2026, Open access, Preprint, not yet peer-reviewed



Comments
Be the first to comment.